Fact CheckerSign in

NCT03787745Recruiting

Ischemic Postconditioning in STEMI Patients Treated With Primary PCI

The Effect of Ischemic Postconditioning in Patients With STEMI Undergoing Primary PCI (DANAMI4-iPOST2)

Source: ClinicalTrials.gov · Last updated 30 Mar 2026

Brief summary (registry, in English)

In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCI

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1800 (estimated)
First submitted
19 Dec 2018
Start date
4 Feb 2019
Primary completion date
31 May 2026
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
NCT number
NCT03787745

What you commit to

  • Study type: Interventional
  • Planned participants: 1800
  • From 4 Feb 2019 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Potential pregnancy
  • Refusal to participate
  • OHCA without subsequent consciousness despite ROSC
  • Thrombectomy considered unavoidable

Who the study is looking for

  • Age ≥18 years
  • Acute onset of chest pain with \< 12 hours duration
  • STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI.
  • TIMI flow 0-1 in infarct related artery

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Heart Center, Rigshospitalet, University of Copenhagen
Coordinator of this site? Confirm its status
CopenhagenDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.